Acteoside inhibited IL-32-induced macrophage-like cell differentiation.
Acteoside decreased IL-32-induced production of TSLP, IL-1β, TNF-α, and IL-8.
Acteoside inhibited IL-32-induced activation of caspase-1and NF-κB.
Acteoside inhibited LPS-induced production of proinflammatory cytokines and NO.